EmpowerPharm First To Receive Health Canada Approval To Make Prescription CBD Drug

Also in Canada, an #Ontario #pharmaceutical company becomes the first in the country to receive regulatory approval for the manufacture of cannabis-derived prescription drugs. Burlington-based EmpowerPharm, which was founded in 2018, received a Drug Establishment License from Health Canada, certifying compliance with #GMP standards. The clinical-stage company already holds licenses authorizing #cannabis production, processing, and research, and credits the new certification to their state-of-the-art 30 #million #dollar manufacturing facility and its research and development capabilities, along with their quality management system. They are currently conducting trials to advance the development of their new #cannabidiol anxiety medication, Empower CBD, to prove its safety, efficacy, and quality. This comes as #Canadians experience record levels of anxiety in the wake of the #coronavirus #pandemic, with a quarter of #citizens reporting the condition in a #February poll. Once EmpowerPharm establishes enough evidence of their #anxiety #medication’s #therapeutic benefit, they plan to seek #marketing approval from #Health #Canada, as well as the #US #FDA.

Distributed by: Cannabis Broadcast Station/ Infinity Broadcast Network Sponsored by: Infinity Inc.
http://www.cannabisbroadcaststation.com

Follow Us on IG, Twitter, Facebook: @cannabisbroadcaststaion @cannabissnacks
#cannabisnews #news

William Bradley

William Bradley

Editor and webmaster.

Leave a Reply